A detailed history of Rockefeller Capital Management L.P. transactions in Organon & Co. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 17,895 shares of OGN stock, worth $342,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,895
Previous 20,014 10.59%
Holding current value
$342,868
Previous $376,000 1.6%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $36,976 - $46,533
-2,119 Reduced 10.59%
17,895 $370,000
Q1 2024

May 14, 2024

SELL
$13.78 - $18.8 $133,101 - $181,589
-9,659 Reduced 32.55%
20,014 $376,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $37,591 - $59,459
3,433 Added 13.08%
29,673 $427,000
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $88,291 - $126,503
5,322 Added 25.44%
26,240 $455,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $34,069 - $43,545
-1,768 Reduced 7.79%
20,918 $435,000
Q1 2023

May 17, 2023

SELL
$21.42 - $32.08 $22,491 - $33,684
-1,050 Reduced 4.42%
22,686 $532,000
Q4 2022

Mar 06, 2023

SELL
$23.31 - $28.61 $11,445 - $14,047
-491 Reduced 2.03%
23,736 $661,000
Q3 2022

Nov 02, 2022

SELL
$23.4 - $34.25 $4,960 - $7,261
-212 Reduced 0.87%
24,227 $565,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $55,626 - $68,347
-1,757 Reduced 6.71%
24,439 $822,000
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $98,262 - $127,014
-3,227 Reduced 10.97%
26,196 $912,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $273,368 - $354,034
-9,535 Reduced 24.48%
29,423 $893,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $130,237 - $162,126
-4,549 Reduced 10.46%
38,958 $1.28 Million
Q2 2021

Aug 10, 2021

BUY
$28.45 - $38.0 $1.24 Million - $1.65 Million
43,507 New
43,507 $1.32 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.87B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.